acyclovir
Generic: acyclovir
Labeler: zydus lifesciences limitedDrug Facts
Product Profile
Brand Name
acyclovir
Generic Name
acyclovir
Labeler
zydus lifesciences limited
Dosage Form
CAPSULE
Routes
Active Ingredients
acyclovir 200 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
65841-829
Product ID
65841-829_60403e35-9772-472d-ba86-f4f373060ee9
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA204313
Listing Expiration
2026-12-31
Marketing Start
2016-05-03
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
65841829
Hyphenated Format
65841-829
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
acyclovir (source: ndc)
Generic Name
acyclovir (source: ndc)
Application Number
ANDA204313 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 200 mg/1
Packaging
- 100 CAPSULE in 1 BOTTLE (65841-829-01)
- 500 CAPSULE in 1 BOTTLE (65841-829-05)
- 30 CAPSULE in 1 BOTTLE (65841-829-06)
- 1000 CAPSULE in 1 BOTTLE (65841-829-10)
- 90 CAPSULE in 1 BOTTLE (65841-829-16)
Packages (5)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "60403e35-9772-472d-ba86-f4f373060ee9", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["197310"], "spl_set_id": ["395cd839-21e1-43e2-a8ce-078f07bc7668"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Zydus Lifesciences Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (65841-829-01)", "package_ndc": "65841-829-01", "marketing_start_date": "20160503"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (65841-829-05)", "package_ndc": "65841-829-05", "marketing_start_date": "20160503"}, {"sample": false, "description": "30 CAPSULE in 1 BOTTLE (65841-829-06)", "package_ndc": "65841-829-06", "marketing_start_date": "20160503"}, {"sample": false, "description": "1000 CAPSULE in 1 BOTTLE (65841-829-10)", "package_ndc": "65841-829-10", "marketing_start_date": "20160503"}, {"sample": false, "description": "90 CAPSULE in 1 BOTTLE (65841-829-16)", "package_ndc": "65841-829-16", "marketing_start_date": "20160503"}], "brand_name": "acyclovir", "product_id": "65841-829_60403e35-9772-472d-ba86-f4f373060ee9", "dosage_form": "CAPSULE", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "65841-829", "generic_name": "acyclovir", "labeler_name": "Zydus Lifesciences Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "200 mg/1"}], "application_number": "ANDA204313", "marketing_category": "ANDA", "marketing_start_date": "20160503", "listing_expiration_date": "20261231"}